Serenova A/S: Financial statements 2017
CVR: 30532228
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Serenova A/S (CVR 30532228) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -4,310,479 and a net result of DKK 274,143,139 compared with DKK -104,050,880 the year before. Equity in the 2017 report amounted to DKK 274,192,791. The solvency ratio was 86.3%.
- Gross Profit
- DKK -4,310,479
- Profit/Loss
- DKK 274,143,139
- Equity
- DKK 274,192,791
- Total Assets
- DKK 317,798,327
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -4.3 mio. | 274.1 mio. | 274.2 mio. | 0 |
| 2016 | - | -9.2 mio. | -104.1 mio. | 50 t. | 7 |
| 2015 | 153 t. | - | -33.9 mio. | 61.2 mio. | - |
| 2014 | 786 t. | - | -22.2 mio. | 33.7 mio. | - |
| 2012 | - | -77 t. | -333 t. | 10.3 mio. | 2 |
Official annual report
Keep an eye on Serenova A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Serenova A/S has published its annual report for 2016. Gross profit came to DKK -9,201,359, and the net result was DKK -104,050,880.
As of April 25, 2017, Søren Bech Justesen has left the board of directors of Serenova A/S.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.